0001916275-22-000002.txt : 20220331 0001916275-22-000002.hdr.sgml : 20220331 20220331102954 ACCESSION NUMBER: 0001916275-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220331 DATE AS OF CHANGE: 20220331 EFFECTIVENESS DATE: 20220331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Incyclix Bio, LLC CENTRAL INDEX KEY: 0001916275 IRS NUMBER: 850766611 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-439787 FILM NUMBER: 22789973 BUSINESS ADDRESS: STREET 1: 600 PARK OFFICES DRIVE, SUITE 355 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: (919) 328-0003 MAIL ADDRESS: STREET 1: 600 PARK OFFICES DRIVE, SUITE 355 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 FORMER COMPANY: FORMER CONFORMED NAME: ARC Therapeutics, LLC DATE OF NAME CHANGE: 20220309 D 1 primary_doc.xml X0708 D LIVE 0001916275 Incyclix Bio, LLC 600 PARK OFFICES DRIVE, SUITE 355 RESEARCH TRIANGLE PARK NC NORTH CAROLINA 27709 (919) 328-0003 DELAWARE ARC Therapeutics, LLC Limited Liability Company true 2020 Fredric N. Eshelman c/o Incyclix Bio, LLC 600 Park Offices Drive, Suite 355 Research Triangle Park NC NORTH CAROLINA 27709 Executive Officer Director Executive Officer and member of the Board of Managers. Patrick Roberts c/o Incyclix Bio, LLC 600 Park Offices Drive, Suite 355 Research Triangle Park NC NORTH CAROLINA 27709 Executive Officer Director Executive Officer and member of the Board of Managers. Sid Subramony c/o Incyclix Bio, LLC 600 Park Offices Drive, Suite 355 Research Triangle Park NC NORTH CAROLINA 27709 Director Member of the Board of Managers. Pharmaceuticals Decline to Disclose 06b false 2022-02-22 false true false 0 29999917 11999940 17999977 The offering is fully subscribed and the remaining $17,999,977 of the securities will automatically close upon the achievement of a specified milestone. false 5 0 0 0 Other than the payment of salaries and other compensation and benefits and reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering. false Incyclix Bio, LLC /s/ Patrick Roberts Patrick Roberts Chief Executive Officer 2022-03-31